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Hematopoiesis: Wandering progenitor cells
Laurence A. Lasky
The generation of mice that are chimeric for expression
of a4 integrin has revealed a critical role for this
adhesion molecule, specifically in postnatal
lymphopoiesis.
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Like the Jews of old wandering in the desert, longing to
find a permanent homeland, hematopoietic stem cells
spend much of their time roaming throughout the embryo
during vertebrate development [1]. Embryonic hemato-
poiesis in the mouse begins at about day 7.5 of gestation in
both an extraembryonic site, the yolk sac blood islands,
and an intraembryonic site, the para-aortic splanchnopleur
or aortic–gonad–mesonephros region. Stem cells, poten-
tially from both of these disparate sites, then migrate to
the fetal liver, where they take up temporary residence
from approximately day 11 through day 15 of fetal devel-
opment. Ultimately, the cells emigrate to the bone
marrow, where they finally arrive at their permanent site
of residence for the rest of the lifetime of the organism.
These migratory waves during embryonic development
probably serve to move the hematopoietic stem and prog-
enitor cells to different stromal microenvironments, where
diverse growth and differentiation factor milieus can exert
their appropriately timed effects.
As these diasporas require that the hematopoietic stem
and progenitor cells lodge in highly specific anatomic
sites, it is likely that they involve one or more adhesion
systems. Because of the difficulty of studying hemato-
poiesis in vivo, the adhesion systems that might poten-
tially be involved in either embryonic or adult
hematopoiesis have been studied mostly in in vitro stromal
systems. The approach has been to analyze the effects of
blocking antibodies on the adhesion and expansion of
progenitor cell types in vitro. The results of such experi-
ments have suggested that the a4b1 integrin may be
involved in several aspects of hematopoiesis. For example,
this integrin has been found to play a role in the attach-
ment of hematopoietic progenitor cells to bone marrow
stromal cells, and it has also been implicated in B-cell
development [2]. Both the immunoglobulin-G-like vascu-
lar cell adhesion molecule-1 (VCAM-1) and fibronectin
ligands for the a4b1 integrin have been associated with
these effects [3–5].
Interestingly, in vivo studies have revealed that adminis-
tration of blocking antibodies directed against the a4b1
integrin result in a profound release of progenitor cells
from bone marrow, and this antibody also inhibits the
engraftment of progenitor cells in this hematopoietic com-
partment [6]. Lastly, the  in vivo engraftment of fetal liver
by hematopoietic progenitors has been found to be inhib-
ited by lack of the b1 integrin subunit [7]. Together, these
results argue strongly that the a4b1 adhesion molecule,
and possibly other b1 integrins, play a role in adult, and
conceivably also fetal, hematopoiesis.
The role of mammalian gene products in vivo is currently
best analyzed using what is now a standard procedure: the
generation of ‘knockout’ mice by targeted gene inactiva-
tion in totipotent embryonic stem (ES) cells. Although
this technique is extraordinarily powerful, the analysis of
such mutant animals is hindered if they die during
embryogenesis. In the case of the a4 integrin knockout
mice, the homozygous animals die early during embryoge-
nesis, and the lethality is manifested by a failure of the
chorion to fuse with the allantois, as well as cardiac defects
[8]. This lethality thus precludes the analysis of the role of
this integrin in embryonic and adult hematopoiesis.
There is, however, another way of investigating at least
the effects on hematopoiesis of a mutation that is lethal to
the whole animal. This is to produce chimeric mice whose
blood system is derived wholly or in part from ES cells in
which both alleles of the gene of interest have been
knocked out [9]. Using surface markers specific for the
ES-derived hematopoietic cells, the contribution of these
cells to various mature hematopoietic lineages can be
assessed. An additional twist is to use mice deficient in
RAG1 and RAG2, enzymes involved in the recombination
events that construct functional immunoglobulin and T-
cell receptor genes from their germline parts in B and T
cells, respectively. Such mice cannot make their own B
and T cells, so when they are used as ES-cell recipients,
all of the B and T cells of the resulting chimeric animals
are derived from the ES cells. It is this system that Arroyo
et al. [10] have recently used to analyze the in vivo func-
tions of the a4 integrin in fetal and adult hematopoiesis.
Using this chimeric mouse system, Arroyo et al. [10] have
made a number of interesting observations. Perhaps unex-
pectedly, given previous in vitro data, they found that T
cells lacking the a4 integrin developed normally during
embryogenesis. However, these cells disappeared with
time after birth, so that by one month they were absent. At
this age the thymus was also affected and became atrophic,
again suggesting a deficiency in T-cell production. These
observations indicate that the embryonic development of
these hematopoietic cells was normal, but that their post-
natal maintenance was deficient. The development of B
cells derived from the mutant ES cells was found to be
severely compromised in the chimeric mice, and this defi-
ciency in peripheral B cells was mirrored by a deficiency of
bone marrow B-cell progenitors.
Interestingly, the reconstitution of sub-lethally irradiated
recipient animals with bone marrow derived from the
chimeric animals revealed that T cells can develop
without this integrin, although B-cell development was
again severely compromised. This latter result suggests
that thymic homing and differentiation of T cells does not
require the a4 integrin, although this molecule does
appear to have a critical role in B-cell development.
Importantly, this effect was not found in all hematopoietic
lineages. Thus, monocytes and natural killer cells under-
went apparently normal development in the absence of
this adhesion system, suggesting that the defect occurs at
a stage after the development of the partially committed
hematopoietic stem cell.
What are we to make of these interesting observations?
First, they strongly suggest that there is a switch in the
requirement for the a4 integrin in lymphopoiesis when
the animal is born (Fig. 1). Preliminary in vitro data sug-
gested that interactions between hematopoietic progenitor
cells and the surrounding stroma are critical for lymphoid
development and that these interactions apparently
involve the a4 integrin, and the new in vivo experiments
provide further compelling evidence for an important role
for this adhesion system in adult lymphopoiesis. As Arroyo
et al. [10] point out, this requirement could reflect an adhe-
sive mechanism, a signalling mechanism, or both. The
interesting observation that a4 integrin is not required
during embryonic lymphoid development suggests that
the bone marrow compartment changes during the first
postnatal month. Alternatively, another adhesion molecule
may compensate for the loss of the a4 integrin during
embryonic lymphoid development, and this compensatory
state is lost during postnatal growth.
The earlier in vitro studies suggested a role for the a4 inte-
grin in the development of early hematopoietic progenitor
cells [11] as well as of myeloid progenitor cells [2]. As
Arroyo et al. [10] found that only the lymphoid compart-
ment is affected by the absence of a4 integrin, these
earlier observations might have reflected a purely in vitro
phenomenon, but it is also possible that other adhesion
systems come into play during embryogenesis to compen-
sate for the loss of the a4 integrin. And, as mentioned
above, embryonic hematopoietic progenitor cells lacking
the b1 integrin were recently shown [7] to be unable to
contribute to the hematopoietic system of chimeric mice
and to colonize the fetal liver, although they were capable
of differentiating in vitro into all three hematopoietic lin-
eages (Fig. 1). Again, Arroyo et al. [10] found no such
defect in their chimeric mice, suggesting that another
integrin a chain must be involved with fetal liver engraft-
ment by hematopoietic stem cells during embryogenesis.
In summary, the elegant work of Arroyo et al. [10] has
revealed a crucial role for one of the integrins in postnatal
lymphoid development. Together with the work of Hirsch
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Figure 1
Integrin involvement in embryonic and adult
hematopoiesis. The diagram shows the
migratory pathways taken by hematopoietic
progenitor cells before and after birth,
highlighting the steps that have recently been
shown to require integrins. Hematopoiesis
begins during embryogenesis in the yolk sac
and aorta–gonad–mesonephros (AGM)
region; hematopoietic progenitor cells then
migrate to the fetal liver, where a b1 integrin
appears to be required for engraftment [7].
Migration to the bone marrow occurs late in
fetal development, and this is a site of
hematopoiesis postnatally and in adult life.
The a4 integrin appears to be required for the
development of lymphoid lineages postnatally,
but not prenatally [7].
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et al. [7], the results suggest that integrins may play critical
roles in hematopoiesis, both during embryogenesis and
postnatally. The use of such chimeric systems to examine
otherwise lethal knockouts should be manna for the
legions of cell biologists interested in hematopoiesis.
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